Advanced infant HIV infection with Cytomegalovirus coinfection following interruption of maternal antiretroviral therapy: a case report

Main Article Content

Prisillia Brigitta
Adinda Paramitha Sukma Damayanti
Delicia Rudy
I Putu Oka Kresna Jayadi

Keywords

HIV infection, mother-to-child transmission, cytomegalovirus, immune reconstitution inflammatory syndrome

Abstract

Background: Despite major global progress in the prevention of mother-to-child transmission (PMTCT), vertical HIV transmission continues to occur, particularly in settings where continuity of maternal care and viral suppression are not maintained. Infants infected perinatally remain at high risk for rapid disease progression, severe immunosuppression, and early mortality, especially in the absence of timely diagnosis and antiretroviral therapy (ART). Coinfections such as cytomegalovirus (CMV) may further complicate the clinical course and influence management decisions.


Case Presentation: We report a case of a 7-week-old female infant presenting with chronic diarrhea, fever, severe malnutrition, jaundice, and pancytopenia. The infant was born at term via elective cesarean section to a mother with known HIV infection who had discontinued ART prior to and during pregnancy. Neonatal prophylaxis consisted of zidovudine monotherapy based on reported maternal adherence. Early Infant Diagnosis confirmed HIV-1 infection with profound immunosuppression (CD4 37 cells/µL, 2.6%) and a high viral load (2.99 ×10⁶ copies/mL). Further evaluation revealed active CMV infection with significant hepatobiliary involvement. Management included supportive stabilization, treatment of CMV infection, opportunistic infection prophylaxis, and carefully timed ART initiation in the context of severe hepatic dysfunction and risk of immune reconstitution inflammatory syndrome.


Conclusion: This case highlights how disruption along the PMTCT cascade, including interruption of maternal ART and misclassification of neonatal transmission risk, can lead to advanced HIV disease in early infancy despite obstetric preventive measures. Sustained maternal viral suppression, accurate perinatal risk assessment, and timely initiation of ART remain critical to preventing severe pediatrics HIV.

Downloads

Download data is not yet available.
Abstract 284 | PDF Downloads 367

References

1. UNAIDS. Country factsheets: Indonesia 2023 [Internet]. Geneva: Joint United Nations Programme on HIV/AIDS; 2023 [Cited 2025 December 11th]. [Available from: https://www.unaids.org/en/resources/presscentre/pressreleaseandstatementarchive/2023/july/unaids-global-aids-update].
2. Volmink J, Marais B. HIV: mother-to-child transmission. BMJ Clin Evid. 2008;2008:0909.
3. Astawesegn FH, Mannan H, Stulz V, Conroy E. Understanding the uptake and determinants of prevention of mother-to-child transmission of HIV services in East Africa: Mixed methods systematic review and meta-analysis. PLoS One. 2024;19(4):e0300606. doi:10.1371/journal.pone.0300606.
4. HHS Panel on Treatment of HIV During Pregnancy and Prevention of Perinatal Transmission— A Working Group of the Office of AIDS Research Advisory Council (OARAC). Recommendations for the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce Perinatal HIV Transmission in the United States. [Updated 2026 Mar 31]. In: ClinicalInfo.HIV.gov [Internet]. Rockville (MD): US Department of Health and Human Services; 2002. [Available from: https://www.ncbi.nlm.nih.gov/books/NBK586310/].
5. UNICEF. HIV – paediatric treatment and care [Internet]. New York (NY): United Nations Children’s Fund; 2025 [Cited 2025 Dec 11th]. [Available from: https://data.unicef.org/topic/hivaids/paediatric-treatment-and-care/].
6. Wiratanti F. Memahami HIV pada anak: dari pencegahan hingga dukungan keluarga [Internet]. Jakarta: Kementerian Kesehatan Republik Indonesia; 2025 [Cited 2025 Dec 11th]. [Available from: https://ayosehat.kemkes.go.id/memahami-hiv-pada-anak-dari-pencegahan-hingga-dukungan-keluarga].
7. Bashir N, Haider N, Farooq A, Hussain M. Epidemiology and clinical spectrum of pediatric patients with human immunodeficiency virus (HIV) infection: A 15 years' experience. Pak J Med Sci. 2023;39(3):820-824. doi:10.12669/pjms.39.3.6710.
8. Basile FW, Fedele MC, Lo Vecchio A. Gastrointestinal Diseases in Children Living with HIV. Microorganisms. 2021;9(8):1572. doi:10.3390/microorganisms9081572.
9. Priyanto MH, Faizun M. Pancytopenia as a marker of advanced human immunodeficiency virus (HIV) infection: how often? A case study accompanied by literature. Indonesian Health Journal. 2024;3(4):306-312. doi:10.58344/ihj.v3i4.603.
10. World Health Organization (WHO). Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care [Internet]. Geneva: World Health Organization; 2021 [cited 2025 Dec 20th]. [Available from: https://www.who.int/publications/i/item/9789240031593].
11. PENTA Steering Committee, Welch S, Sharland M, Lyall EG, Tudor-Williams G, Niehues T, et al. PENTA 2009 guidelines for the use of antiretroviral therapy in paediatric HIV-1 infection. HIV Med. 2009;10(10):591-613. doi:10.1111/j.1468-1293.2009.00759.x.
12. Tuthill EL, Odhiambo BC, Maltby AE. Understanding mother-to-child transmission of HIV among mothers engaged in HIV care in Kenya: a case report. Int Breastfeed J. 2024;19(1):14. Published 2024 Feb 24. doi:10.1186/s13006-024-00622-3.
13. Hurst SA, Appelgren KE, Kourtis AP. Prevention of mother-to-child transmission of HIV type 1: the role of neonatal and infant prophylaxis. Expert Rev Anti Infect Ther. 2015;13(2):169-181. doi:10.1586/14787210.2015.999667.
14. European Collaborative Study, Boer K, England K, Godfried MH, Thorne C. Mode of delivery in HIV-infected pregnant women and prevention of mother-to-child transmission: changing practices in Western Europe. HIV Med. 2010;11(6):368-378. doi:10.1111/j.1468-1293.2009.00800.x.
15. Fawzi W, Msamanga G, Renjifo B, Spiegelman D, Urassa E, Hashemi L, et al. Predictors of intrauterine and intrapartum transmission of HIV-1 among Tanzanian women. AIDS. 2001;15(9):1157-1165. doi:10.1097/00002030-200106150-00011.
16. Shah S, Sobolewski B. Management of HIV in pregnancy. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. [Available from: https://www.ncbi.nlm.nih.gov/books/NBK565879/].
17. ACOG Committee Opinion No. 751: Labor and Delivery Management of Women With Human Immunodeficiency Virus Infection. Obstet Gynecol. 2018;132(3):e131-e137. doi:10.1097/AOG.0000000000002820.
18. Njom Nlend AE. Mother-to-Child Transmission of HIV Through Breastfeeding Improving Awareness and Education: A Short Narrative Review. Int J Womens Health. 2022;14:697-703. doi:10.2147/IJWH.S330715.
19. Stachowiak A, Sobolewska-Pilarczyk M, Pawłowska M. Effective prophylaxis of vertical HIV transmission despite late diagnosis of the mother’s infection. HIV AIDS Rev. 2019;18(3):228–231. doi:10.5114/hivar.2019.85950.
20. Kementerian Kesehatan Republik Indonesia. Pedoman Nasional Pelayanan Kedokteran (PNPK) HIV. Jakarta: Kemenkes RI; 2019.
21. Australian HIV Guidelines: When to initiate therapy in ARV-naive children [Internet]. ASHM; 2024 [Cited 2024 May 21st]. [Available from: https://hiv.guidelines.org.au/arv-pediatric/initiate-therapy/].
22. Pokorska-Śpiewak M, Stańska-Perka A, Popielska J, Ołdakowska A, Coupland U, Zawadka K, et al. Prevalence and predictors of liver disease in HIV-infected children and adolescents. Sci Rep. 2017;7(1):12309. doi:10.1038/s41598-017-11489-2.
23. Zhao M, Zhuo C, Li Q, Liu L. Cytomegalovirus (CMV) infection in HIV/AIDS patients and diagnostic values of CMV-DNA detection across different sample types. Ann Palliat Med. 2020;9(5):2710-2715. doi:10.21037/apm-20-1352.
24. Gyawali J, Pudasainee-Kapri S, Agrawal S, Khatri DB, Adhikari S, Dhunagana PP. Cytomegalovirus-associated pancytopenia in a four-month-old infant: a case report. BMC Infect Dis. 2024;24(1):1277. doi:10.1186/s12879-024-10191-9.
25. New York State Department of Health AIDS Institute. Management of immune reconstitution inflammatory syndrome (IRIS) [Internet]. New York: NYSDOH AI; 2023 [Cited 2026 Jan 6th]. [Available from: https://www.hivguidelines.org/guideline/hiv-iris/].
26. Archary M, Sartorius B, La Russa P, Sibaya T, Healy M, Bobat RA. Effect of the Timing of Antiretroviral Treatment Initiation on Outcomes in Children Living With Human Immunodeficiency Virus Admitted With Severe Acute Malnutrition. J Pediatric Infect Dis Soc. 2021;10(3):259-266. doi:10.1093/jpids/piaa054.
27. Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV. Guidelines for the use of antiretroviral agents in pediatric HIV infection [Internet]. Bethesda (MD): National Institutes of Health; 2023 [Cited 2026 Jan 15th]. [Available from: https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/when-initiate-therapy-antiretroviral-naive-children].